Replies to post #7627 on Pluristem Therapeutics Inc (PSTI)

[Kronberg]

Stox IMO, Pluristem acts quite well.Over the last 2 months we received 10 NR and the stock price added about 64 % from the beginning of September.IMO, Pluristem will not receive initial order this year. But if I'm wrong and we get an order of say 0.2-0.3% of the number that counted the woman with a well-developed sense of imagination or hit other significant milestones we'll go higher. If you want to see the stock "under the radar" you can compare Protalix Therapeutics (PLX) $94 M m/c and Amicus Therapeutics (FOLD) $2.3 B m/c.